Section scientifique
565 articles publiés dans publications évaluées par experts jusqu'à présent
-
Granulocyte and monocyte apheresis therapy for patients with active ulcerative colitis associated with COVID-19
- Efficacy of apheresis as maintenance therapy for patients with ulcerative colitis in an open-label prospective multicenter randomised controlled trial
- Evidence-based clinical practice guidelines for inflammatory bowel disease 2020
- Leukocytapheresis for rheumatoid arthritis cases that are super-resistant to any class of biological drugs and tofacitinib
- Refractory Ulcerative Colitis Improved by Scheduled Combination Therapy of Vedolizumab and Granulocyte and Monocyte Adsorptive Apheresis
- Selective granulocyte and monocyte apheresis in inflammatory bowel disease: Its past, present and future
- Leukocytapheresis Therapy for Rheumatoid Arthritis: Results Compared with Control Trial
- Inflammatory Bowel Disease in Japan Is It Similar to or Different from Westerns?
- Security of therapeutic apheresis in pediatrics. prospective study during 2018 in 171 apheresis sessions
-
Exploratory Study of the Effectiveness of Granulocyte and Monocyte Adsorptive Apheresis Before Initiation of Steroids in Patients With Active Ulcerative Colitis (EXPECT Study): A Multicenter Prospective Clinical Trial
- Safety and efficacy of single-needle leukocyte apheresis for treatment of ulcerative colitis
- Apheresis in Inflammatory Bowel Disease: Current Evidence
Contactez-nousPour en savoir plus
Contactez-nous